Patients Deaths and Data Shortfall Spell the End for Cell Therapy Biotech Artiva
Artiva Biotherapeutics attributed one of the fatalities to a drug used to prepare patients for…
Patients Deaths and Data Shortfall Spell the End for Cell Therapy Biotech Artiva
Artiva Biotherapeutics attributed one of the fatalities to a drug used to prepare patients for cell therapy and not to the cell therapy itself. But Artiva’s setbacks follow safety signals reported for autoimmune disease cell therapy programs from Novartis and Bristol Myers Squibb. The post Patients Deaths and Data Shortfall Spell the End for Cell…
HCAHPS 2.0 Is Not a Survey Update. It’s a Strategic Shift for Healthcare
By XAVIER WARTELLE The Metric Healthcare Could Never Move One statistic should capture the attention of every hospital executive. A peer-reviewed analysis published in Medical Care examined HCAHPS (Hospital Consumer Assessment of Healthcare Providers and Systems) performance across nearly 4,000 U.S. hospitals over an eleven-year period. Nearly every measured category improved meaningfully except one. Overall…
Frequently Asked Questions about the ACA’s Health Insurance Marketplace
What are premium tax credits and how do they work? How much can I earn and qualify for premium tax credits in the Marketplace? What income is counted in determining my eligibility for premium tax credits? Who is eligible for Marketplace premium tax credits? Can I buy health insurance outside of the Marketplace that meets…
Preguntas frecuentes sobre el Mercado de Seguros Médicos de la Ley de Cuidado de Salud a Bajo Precio
¿Cómo funcionan los subsidios para las primas? ¿Cuánto puedo ganar y calificar para subsidios para las primas en el mercado? ¿Qué ingreso cuenta para determinar mi elegibilidad para recibir subsidios? ¿Quién es elegible para recibir subsidios para las primas? ¿Puedo comprar un seguro de salud por fuera del mercado que cumpla con todos los estándares…
HCA CEO: Exchange Attrition Will Be a ’27 Problem, Too
Patients formerly covered by exchange plans cost the health system operator another $400 million last quarter and accounted for more than 10 percent of adjusted admissions.
AcademyHealth Blueprint Calls for Stronger, More Independent Federal Health Research
AcademyHealth CEO Aaron Carroll, M.D., M.S., discusses recommendations for strengthening the federal systems that produce and use health research, data, and evaluation
ClarityCare Raises $16.5M to Speed Up Prior Authorizations
As health plans grapple with new federal deadlines for prior authorization decisions, healthcare AI startup ClarityCare has raised $16.5 million to automate the administrative workload that can keep patients waiting for the care they need. The post ClarityCare Raises $16.5M to Speed Up Prior Authorizations appeared first on MedCity News.
Midterm Election Update: Immigrant Health Policy
Immigration restrictions and enforcement are central to the Trump administration’s domestic agenda and a focus of debate in the 2026 midterm elections. These policies have ripple effects on health care: immigration-related fears are leading some immigrant families to avoid medical care and drop coverage, including for U.S. citizen children, and visa restrictions could strain a…
HealthTap Connects Patients, Doctors and DME Suppliers
HealthTap CEO Sean Mehra says partnerships with durable medical equipment vendors connect patients with primary care physicians when they need a clinical evaluation, documentation or orders
A Market, Not a Mandate, Is the Fastest Way to Bring AI Into Hospitals
The cost of waiting is not evenly distributed. Rural and critical access hospitals report under 50 percent adoption of even basic predictive tools, compared with 86 percent among top-tier system-affiliated hospitals. Every year without a bridge widens that gap, and it widens it fastest for the hospitals with the least room to absorb it. The…
